USX:GRAY - Graybug Vision, Inc Graybug Vision, Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 4.13    -0.290 (-6.56%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

23 Jul 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Frederic Guerard Pharm.D.

IPO: 2020-09-25

Headquarters: US

Employees: 32

Homepage

Description

Graybug Vision Inc is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. The company's products under pipeline are GB-102, for the treatment of wet age-related macular degeneration, or wet AMD, and diabetic macular edema, or DME; GB-103; and GB-401.